CN115443131A - 截短侧耳素类化合物的治疗用途 - Google Patents

截短侧耳素类化合物的治疗用途 Download PDF

Info

Publication number
CN115443131A
CN115443131A CN202180028994.6A CN202180028994A CN115443131A CN 115443131 A CN115443131 A CN 115443131A CN 202180028994 A CN202180028994 A CN 202180028994A CN 115443131 A CN115443131 A CN 115443131A
Authority
CN
China
Prior art keywords
acetyl
hydroxy
cyclohexylsulfanyl
compound
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180028994.6A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·哈夫纳
苏珊·帕克纳
沃尔夫冈·威查
罗斯玛丽·里德尔
兹林卡·伊维齐克-舍恩费尔德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Nabriva Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics AG filed Critical Nabriva Therapeutics AG
Publication of CN115443131A publication Critical patent/CN115443131A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/16—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202180028994.6A 2020-04-17 2021-04-16 截短侧耳素类化合物的治疗用途 Pending CN115443131A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063011474P 2020-04-17 2020-04-17
EP20170072.1 2020-04-17
US63/011,474 2020-04-17
EP20170072 2020-04-17
EP20183292.0 2020-06-30
EP20183292 2020-06-30
PCT/EP2021/025140 WO2021209174A1 (en) 2020-04-17 2021-04-16 Therapeutic use of pleuromutilins

Publications (1)

Publication Number Publication Date
CN115443131A true CN115443131A (zh) 2022-12-06

Family

ID=75801547

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180028994.6A Pending CN115443131A (zh) 2020-04-17 2021-04-16 截短侧耳素类化合物的治疗用途

Country Status (9)

Country Link
US (1) US20230174472A1 (https=)
EP (1) EP4135682A1 (https=)
JP (2) JP2023522644A (https=)
CN (1) CN115443131A (https=)
BR (1) BR112022020007A2 (https=)
CA (1) CA3180535A1 (https=)
IL (1) IL297268A (https=)
TW (1) TW202203908A (https=)
WO (1) WO2021209174A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025093003A1 (zh) * 2023-11-03 2025-05-08 阳光安津(南京)生物医药科技有限公司 一种化合物在制备用于治疗银屑病的药物中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250134844A1 (en) 2022-02-09 2025-05-01 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1896404A1 (en) * 2005-06-27 2008-03-12 Nabriva Therapeutics Forschungs GmbH Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
WO2009106839A1 (en) * 2008-02-28 2009-09-03 Cambridge Enterprise Limited Use of tiamulin as an antiviral agent
CN101668738A (zh) * 2007-03-20 2010-03-10 纳布里瓦治疗股份公司 用于治疗微生物介导的疾病的截短侧耳素衍生物
CN103080083A (zh) * 2010-05-26 2013-05-01 纳布里瓦治疗股份公司 制备截短侧耳素的工艺
CN110507823A (zh) * 2019-08-20 2019-11-29 中国医学科学院基础医学研究所 衣康酸相关物质在诊断、防治病毒感染性疾病中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103204787B (zh) 2012-01-17 2014-10-01 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
CN103242210B (zh) 2012-02-09 2014-09-24 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
KR102656841B1 (ko) 2015-06-17 2024-04-12 나브리바 테라퓨틱스 게엠베하 레파뮬린의 주사가능한 약제학적 제형

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1896404A1 (en) * 2005-06-27 2008-03-12 Nabriva Therapeutics Forschungs GmbH Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
CN101668738A (zh) * 2007-03-20 2010-03-10 纳布里瓦治疗股份公司 用于治疗微生物介导的疾病的截短侧耳素衍生物
WO2009106839A1 (en) * 2008-02-28 2009-09-03 Cambridge Enterprise Limited Use of tiamulin as an antiviral agent
CN103080083A (zh) * 2010-05-26 2013-05-01 纳布里瓦治疗股份公司 制备截短侧耳素的工艺
CN110507823A (zh) * 2019-08-20 2019-11-29 中国医学科学院基础医学研究所 衣康酸相关物质在诊断、防治病毒感染性疾病中的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025093003A1 (zh) * 2023-11-03 2025-05-08 阳光安津(南京)生物医药科技有限公司 一种化合物在制备用于治疗银屑病的药物中的应用

Also Published As

Publication number Publication date
CA3180535A1 (en) 2021-10-21
JP2023522644A (ja) 2023-05-31
IL297268A (en) 2022-12-01
BR112022020007A2 (pt) 2022-11-22
WO2021209174A1 (en) 2021-10-21
EP4135682A1 (en) 2023-02-22
TW202203908A (zh) 2022-02-01
US20230174472A1 (en) 2023-06-08
JP2026041886A (ja) 2026-03-10

Similar Documents

Publication Publication Date Title
JP2026041886A (ja) プレウロムチリンの治療的使用
EP4135683B1 (en) Antiviral use of pleuromutilins
US20150110767A1 (en) Methods for treating lung infections and inflammation
JP2017531038A (ja) 新規５，６−ジヒドロ−４Ｈ−ベンゾ［ｂ］チエノ−［２，３−ｄ］アゼピン誘導体
US20220193073A1 (en) Method of treating fibrosis
CN113272298B (zh) 用于治疗呼吸系统疾病的化合物和组合物
WO2020241759A1 (ja) インフルエンザウイルス感染症またはコロナウイルス感染症の予防および／または治療剤
KR20200010302A (ko) 세균 이차 감염의 치료 및/또는 예방에 사용하기 위한 il-8 억제제
EP4072675B1 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
JP2023520917A (ja) 呼吸器状態を処置するためのｔｒｐｃ６阻害剤
KR20220127824A (ko) 알파1-항트립신 결핍의 치료를 위한 4-((2-옥소피리딘-1(2h)-일)메틸)벤즈아미드
EP4073043B1 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
JP2002511416A (ja) 感染を処置および予防するための方法
EP4135681B1 (en) Antiviral use of pleuromutilins
EP4346789B1 (en) Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis
EP4125924B1 (en) Furosemide compositions for use in supportive therapy in coronavirus infection
CN114053288B (zh) 肺部疾病治疗的组合物和方法
WO2023038815A1 (en) Irak inhibitor for treating cytokine release-related conditions associated with infection by a respiratory virus
US20230127198A1 (en) Compositions and methods for the treatment of toxic gas exposure
US20080207577A1 (en) Combination I
JP2009533428A (ja) 筋肉内抗ウイルス処置
WO2025257398A1 (en) Dicarboxylic acids and esters thereof for use in the treatment of a viral lung infection
HK40076778A (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
HK40076778B (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
Walker American Thoracic Society (ATS) 2014 International Conference-San Diego, California, USA-May 16-21, 2014

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20230912

Address after: No. 6-8, Doshucho 2-chome, Chuo-ku, Osaka City, Osaka, Japan

Applicant after: SUMITOMO PHARMACEUTICALS CO.,LTD.

Address before: Austria Vienna

Applicant before: NABRIVA THERAPEUTICS AG

TA01 Transfer of patent application right
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20221206

WD01 Invention patent application deemed withdrawn after publication